Insulin shortage reported in Pakistan after German manufacturer halts supplies
Most outlets reported that Pakistan is facing a shortage of an insulin product used by Type 1 diabetes patients after its German manufacturer halted supplies for product upgrades. The National Assembly was informed of the issue, with some outlets specifying the brand as Apidra and the manufacturer as Sanofi. While the framing was largely consistent, a few outlets provided more detail on the cause, such as a production facility disruption in Germany. All excerpts emphasized the impact on patients and the official communication to the National Assembly.
Summary generated by HarZaviya from the headlines and excerpts of the 5 outlets below. Each outlet's own headline is listed under it.
Same story from 5 outlets
Each outlet's own headline, most recent first — read any at its source.
-
Pakistan faces insulin shortage after German firm halts supply, NA told
An insulin product used by patients with Type 1 diabetes is in short supply in Pakistan after its German manufacturer halted supplies while upgrading its products, Parliamentary Secretary for Health Nelson Azeem said on Friday. Responding to a matter raised by MNA Syeda Amna Batool in the National Assembly, Azeem said there had been no […]
-
Pakistan Faces Shortage of Popular Insulin Brand: National Assembly Told
Pakistan is facing a shortage of the insulin brand Apidra after its German manufacturer suspended production for upgrades, the National… Read More
-
Insulin shortage for type 1 diabetes patients reported across Pakistan, NA told
ISLAMABAD: An insulin product used by patients with Type 1 diabetes is in short supply across Pakistan after its German manufacturer halted supplies to upgrade its products, Parliamentary Secretary for Health Nelson Azeem told the National Assembly on Friday. Responding to a matter raised by MNA Syeda Amna Batool, Azeem said the product had been available in the country until September, but sup...
-
Insulin shortage hits Pakistan after German manufa...
Pakistan is facing a shortage of an insulin product used by patients with diabetes after its German manufacturer suspended supplies to upgrade its
-
Insulin product in short supply after German manufacturer halts supplies, NA told
An insulin product used by patients with Type 1 diabetes is in short supply in Pakistan after its German manufacturer halted supplies while upgrading its products, Parliamentary Secretary for Health Nelson Azeem said on Friday. Responding to a matter raised by MNA Syeda Amna Batool in the National Assembly, Azeem said there had been no shortage until June, with stocks available until September....
6 articles from 5 outlets, 23 Oct–24 Oct 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?